Turnover€4.12M+21.0%
EBIT margin-7.4%-38.2pp
Net result€-1.13M-28.2%
Working capital€-3.26M-66.1%
Directors1
Annual accounts & ratios
Source: NBB · 2025Annual accounts filed on 13-04-2026 with the NBB · fiscal year 2025 · verkort
€4.12M
+21.0%
18–25
€-999k
-79.8%
18–25
€-1.13M
-28.2%
18–25
€-1.09M
-71.9%
18–25
€452k
-61.7%
18–25
€-3.87M
-117.5%
18–25
€-3.26M
-66.1%
18–25
22
-32.4%
18–25
€1.05M
-35.7%
18–25
€101
-82.6%
18–25
€3.63M
+22.8%
18–25
€3.61M
+23.1%
18–25
€376
-92.2%
18–25
0.10
-70.7%
18–25
0.06
-69.7%
18–25
-854.6%
-467.9%
18–25
-0.94
+43.6%
18–25
29.2%
-41.1%
18–25
-249.9%
-234.5%
18–25
-7.9%
+90.9%
18–25
1.1%
-97.7%
18–25
-10.94
-53.9%
18–25
Figures by fiscal year
| Fiscal year | 2025 |
|---|---|
| Revenue | — |
| EBITDA | €-999k |
| Net profit | €-1.13M |
| Cash flow | €-1.09M |
| Staff costs | €1.05M |
| Income taxes | €101 |
| Dividends | — |
| Total assets | €452k |
| Equity | €-3.87M |
| Debt | €3.63M |
| of which ≤ 1y | €3.61M |
| of which > 1y | — |
| Working capital | €-3.26M |
| Employees (FTE) | 21.5 |
Ratios (computed)
| 2025 | |
|---|---|
| Current ratio | 0.10 |
| Quick ratio | 0.06 |
| Working capital ratio | -721.1% |
| Solvency | -854.6% |
| Debt / equity | -0.94 |
| Long-term debt ratio | — |
| Interest coverage | -10.94 |
| Gross margin | — |
| Net margin | — |
| ROA | -249.9% |
| ROE | 29.2% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €452k |
| Fixed assets | 21/28 | €102k |
| Tangible fixed assets | 22/27 | €102k |
| Current assets | 29/58 | €350k |
| Stocks & contracts in progress | 3 | €137k |
| Amounts receivable within one year | 40/41 | €166k |
| Cash & bank | 54/58 | €41k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €452k |
| Equity | 10/15 | €-3.87M |
| Contributions / capital | 10/11 | €3.49M |
| Reserves | 13 | €41k |
| Accumulated profits (losses) | 14 | €-7.39M |
| Provisions & deferred taxes | 16 | €687k |
| Amounts payable | 17/49 | €3.63M |
| Amounts payable within one year | 42/48 | €3.61M |
| Trade debts payable within one year | 44 | €297k |
| Income statement | ||
| Gross operating margin | 9900 | €673k |
| Operating result | 9901 | €-1.04M |
| Financial income | 75 | €0 |
| Financial charges | 65 | €91k |
| Result before taxes | 9903 | €-1.13M |
| Income taxes | 67/77 | €101 |
| Net result for the period | 9904 | €-1.13M |
| Result to be appropriated | 9905 | €-1.13M |
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2025 · computed0
/ 100
Critical
Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative — not credit advice.